中文名称: Ceranib-2
英文名称: Ceranib-2
CAS No: 1402830-75-4
分子式: C25H19NO3
分子量: 381.42
C10830 Ceranib-2 ≥98% (psaitong)
包装规格:
5mg 10mg in glass bottle
溶解性:
溶于DMSO(50 mg/mL 超声)
产品描述:

基本信息

产品编号:

C10830

产品名称:

Ceranib-2

CAS:

1402830-75-4

 

储存条件

粉末

-20℃

四年

 

 

分子式:

C25H19NO3

溶于液体

-80℃

6个月

分子量:

381.42

-20℃

1个月

化学名: 

3-[3-(4-Methoxyphenyl)-1-oxo-2-propen-1-yl]-4-phenyl-2(1H)-quinolinone

Solubility (25°C):

 

体外:

 

DMSO

 

Ethanol

 

Water

 

体内(现配现用):

 

1mg/ml表示微溶或不溶。

普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。

 

制备储备液

 

浓度

 

溶液体积

质量

 

1mg

 

5mg

 

10mg

1mM

2.6218mL

13.1089mL

26.2178mL

5mM

0.5244mL

2.6218mL

5.2436mL

10mM

0.2622mL

1.3109mL

2.6218mL

 

生物活性

产品描述

一种有效的非脂质神经酰胺酶(ceramidase)抑制剂,可在SKOV3细胞中抑制细胞神经酰胺酶活性,IC50为28μM。

靶点

IC50:28μM (Ceramidase)

 

体外研究

Ceranib-2 (10nM-10µM;72 hours;SKOV3 cells) treatment inhibits cell proliferation and/or survival with an IC50 value of 0.73μM.Ceranib-2 (0.75-1.5µM;48 hours;SKOV3 cells) treatment causes accumulation of cells in the sub-G1 (apoptosis),G2 and S (0.75μM only) phases of the cell cycle,concomitant with reductions in the number of cells in G1 phase.Ceranib-2 produces a dose-dependent decrease in ceramidase activity, with 50% inhibition at 28μM,induces the accumulation of multiple ceramide species,and decreases levels of sphingosine and S1P.

Cell Proliferation Assay

Cell Line:

SKOV3 cells

Concentration:

10nM-10µM

Incubation Time:

72 hours

Result:

Cell proliferation and/or survival were inhibited with an IC50 value of 0.73μM for Ceranib-2.

Cell Cycle Analysis

Cell Line:

SKOV3 cells

Concentration:

0.75μM,or 1.5μM

Incubation Time:

48 hours

Result:

Induced cell-cycle arrest and cell death.

体内研究

Ceranib-2 (20-50mg/kg;intraperitoneal injection;daily for 5 days per week;for 3 weeks;female Balb/c mice) treatment delays tumor growth in a syngeneic tumor model without hematologic suppression or overt signs of toxicity.Intraperitoneal administration of 50mg/kg Ceranib-2 results in progressive increases in its circulating levels,reaching a peak plasma concentration of approximately 40μM at the 2hr time point.Ceranib-2 appears to be cleared with a half-life of less than 2hr.

Animal Model:

Female Balb/c mice injected with JC murine mammary adenocarcinoma cells

Dosage:

20mg/kg or 50mg/kg

Administration:

Intraperitoneal injection;daily for 5 days per week;for 3 weeks

Result:

Delayed tumor growth in a syngeneic tumor model.

 

保存条件:
-20℃
UN码:
HazardClass:
危害声明:
安全说明:
搜索质检报告(COA)
参考文献 & 客户发表文献

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)

摩尔浓度计算公式

  • =
    *
    *
    *选择对应的单位 *空出希望得到的变量,填写另外两个变量

用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )

  • * = *

连续稀释计算器方程

  • 连续稀释

  • 初始浓度:
  • 稀释倍数:
  • 计算结果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):